1 unchanged sentence
Recent Sales of Unregistered Securities
−Removed: On March 4, 2021, we granted our Chief Legal Officer an option to purchase 325,000 shares of our common stock as an inducement to employment in accordance with Nasdaq Listing Rule 5635(c)(4).
+Added: On June 1, 2021, we granted a new employee an option to purchase 180,000 shares of our common stock as an inducement to employment in accordance with Nasdaq Listing Rule 5635(c)(4).
+Added: The stock option is scheduled to become exercisable as to one-fourth of the shares underlying the option on each anniversary of the new employee’s start date, subject to the recipient’s continued service.
+Added: The option has an exercise price of $3.75 per share.
+Added: On July 1, 2021, we granted a new employee an option to purchase 235,000 shares of our common stock as an inducement to employment in accordance with Nasdaq Listing Rule 5635(c)(4).
+Added: The stock option is scheduled to become exercisable as to one-fourth of the shares underlying the option on each anniversary of the new employee’s start date, subject to the recipient’s continued service.
+Added: The option has an exercise price of $3.77 per share.
No underwriters were involved in the foregoing issuance of securities.
The securities were issued pursuant to Section 4(a)(2) under the Securities Act of 1933, as amended, relating to transactions by an issuer not involving any public offering.
−Removed: The recipient either received adequate information about us or had access, through other relationships, to such information.
−Removed: The stock option is scheduled to become exercisable as to one-fourth of the shares underlying the option on each anniversary of our Chief Legal Officer’s start date, subject to the recipient’s continued service.
−Removed: The option has an exercise price of $8.52 per share.
−Removed: Consulting Agreement, dated as of January 4, 2021, by and between Solid Biosciences Inc.
+Added: The recipients either received adequate information about us or had access, through other relationships, to such information.
+Added: Lease, dated June 15, 2021, between Solid Biosciences, Inc.
+Added: and Hood Park LLC.
+Added: Amendment No.
+Added: 1 to 2020 Stock Incentive Plan (incorporated by reference to Exhibit 99.1 to the Company’s Current Report on Form 8-K (File No.
+Added: 001-38360) filed with the SEC on June 17, 2021).
+Added: 2021 Employee Stock Purchase Plan (incorporated by reference to Exhibit 99.2 to the Company’s Current Report on Form 8-K (File No.
+Added: 001-38360) filed with the SEC on June 17, 2021).
+Added: Form of Nonstatutory Inducement Stock Option Agreement.
Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
14 unchanged sentences
Solid Biosciences Inc.
+Added: August 16, 2021
/s/ Ilan Ganot
1 unchanged sentence
(Principal Executive Officer)
+Added: August 16, 2021
/s/ Stephen DiPalma
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.